HKAPI – 頁面 8

13 十月 23

本會會員參與廣東省藥品醫療器械創新發展論壇

香港科研製藥聯會高級執行董事陳素娟女士，代表本會參與其中一場圓桌討論。

06 十月 23

HKAPI Career Talk at HKU: Nurturing Biopharmaceutical Aspirations

The HR Committee successfully hosted a career talk at the University of Hong Kong, themed 'Why Should You Explore a Bio-Pharmaceutical Career?'.

13 七月 23

Regulatory Intelligence Forum

The HKAPI Regulatory Working Group recently held a forum for its members to exchange views on regulatory intelligence. Around 60 members attended the event.

22 五月 23

HKAPI Welcomes Four New Members

We are excited to share that the HKAPI has welcomed four new members to our organization over the past year. These companies are bringing new and diverse expertise to our organization and we are thrilled to have them on board.

19 五月 23

Pfizer Renewed as HKAPI Full Member

HKAPI is pleased to announce that Pfizer has renewed as full member of the Association.

17 五月 23

HKAPI joined the Panel at 3rd ASGH Project Pitching Sessions

We are delighted to announce that our Senior Executive Director, Ms. Sabrina Chan, was invited by the Hong Kong Trade Development Council (HKTDC) to participate in the 3rd Asia Summit on Global Health (ASGH) as one of the panelists for the Project Pitching Sessions.

13 四月 23

Medical Representatives’ Training Programme 2023

We are thrilled to announce the commencement of the HKAPI Medical Representatives Training Programme 2023. This programme has been providing comprehensive training to medical representatives since the 1980s and has […]

05 四月 23

Appointment of New Board Members

HKAPI has announced the election of two new members to its Board of Directors. Mr Neo Lam, from Baxter, and Mr Jonathan Chin, from Boehringer Ingelheim, have been elected to join the Board and will serve until the end of this term (2024).